Discovery of <b>CN-3</b> as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-05-02
DOI
https://doi.org/10.1021/acs.jmedchem.6c00376
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of CN-3 as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations

Shan‐Liang Sun, Zhou Ming-dan, Yan-Cheng Yu, Zhi‐Hao Shi et al.
Journal of Medicinal Chemistry
Glioma Diagnosis and Treatment
article

Discovery of CN-3 as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations

Shan‐Liang Sun, Zhou Ming-dan, Yan-Cheng Yu, Zhi‐Hao Shi, NG Li, Yuanhui Lai, Y F Yang, Min-Hui Chen, Qian Liu, Zi-Xuan Wang, Meng-Yuan Zhang, Jin Yang, Nuo Qiao, Zhang Zhang, Kun Yang, Rui He
article en

Abstract

No abstract available for this paper.
Journal of Medicinal Chemistry
Nanjing University of Chinese Medicine (CN), China Pharmaceutical University (CN), Ministry of Education (TH)
National Natural Science Foundation of China, Nanjing University of Chinese Medicine
Openalex Percentile: Top 10%
Glioma Diagnosis and Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.